Marella Thorell

Insider Reports History

Entity
Individual
Location
1226 Charter Lane, Ambler, PA
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marella Thorell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Accounting Officer Ordinary Shares 53.1K $423K $7.96 Mar 21, 2022 Direct
Vallon Pharmaceuticals, Inc. Director Common Stock 9.51K $38.8K $4.08 Dec 13, 2022 Direct
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 7.5K $11.4K $1.52 Jun 9, 2022 Direct
Evelo Biosciences, Inc. Chief Financial Officer Common Stock 22.3K $7.35K $0.33 Nov 8, 2023 Direct
Seres Therapeutics, Inc. EVP and Chief Financial Officer Stock Option (Right to Buy) 650K Feb 7, 2025 Direct
Centessa Pharmaceuticals plc Chief Accounting Officer Share Option (right to buy) 67.5K Feb 1, 2022 Direct
ESSA Pharma Inc. Director Options 50K Mar 25, 2024 Direct
Carisma Therapeutics Inc. Director Stock Option (Right to Buy) 38.7K Jul 1, 2024 Direct
Evelo Biosciences, Inc. Chief Financial Officer Restricted Stock Units 6.5K Nov 7, 2023 Direct

Insider Reports Filed by Marella Thorell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MCRB Seres Therapeutics, Inc. Feb 7, 2025 1 $0 4 Feb 11, 2025 EVP and Chief Financial Officer
CARM Carisma Therapeutics Inc. Jul 1, 2024 1 $0 4 Jul 1, 2024 Director
CARM Carisma Therapeutics Inc. Jun 30, 2024 0 $0 3 Jul 1, 2024 Director
EPIX ESSA Pharma Inc. Mar 25, 2024 1 $0 4 Mar 28, 2024 Director
MCRB Seres Therapeutics, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 EVP and Chief Financial Officer
MCRB Seres Therapeutics, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 EVP and Chief Financial Officer; Exhibit List: Exhibit 24 - Power of Attorney
EVLO Evelo Biosciences, Inc. Nov 7, 2023 3 -$598 4 Nov 8, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. Nov 1, 2023 3 -$1.32K 4 Nov 3, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. Sep 11, 2023 1 $0 4 Sep 13, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. Aug 7, 2023 3 -$19.1K 4 Aug 9, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. May 8, 2023 1 -$4.84K 4 May 10, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. May 7, 2023 2 $0 4 May 9, 2023 Chief Financial Officer
EVLO Evelo Biosciences, Inc. Feb 7, 2023 1 $0 4 Feb 9, 2023 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 Director
EVLO Evelo Biosciences, Inc. Sep 1, 2022 1 $0 4 Sep 1, 2022 Chief Financial Officer
EVLO Evelo Biosciences, Inc. Jul 13, 2022 0 $0 3 Jul 18, 2022 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
EPIX ESSA Pharma Inc. Jun 29, 2022 1 $0 4 Nov 1, 2022 Director
GRI Vallon Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CNTA Centessa Pharmaceuticals plc Mar 21, 2022 1 $0 4 Mar 23, 2022 Chief Accounting Officer
CNTA Centessa Pharmaceuticals plc Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Accounting Officer
CNTA Centessa Pharmaceuticals plc Jun 2, 2021 1 $20K 4 Jun 4, 2021 Chief Accounting Officer
CNTA Centessa Pharmaceuticals plc May 27, 2021 4 $0 4 Jun 1, 2021 Chief Accounting Officer
CNTA Centessa Pharmaceuticals plc May 27, 2021 0 $0 3 May 27, 2021 Chief Accounting Officer